Fabrice Andre
MD, PhD
Director of Research
👥Biography 个人简介
Fabrice Andre is a global leader in precision breast cancer medicine who led the DESTINY-Breast06 trial evaluating trastuzumab deruxtecan in HER2-low and HER2-ultralow populations. His work on genomic profiling and ctDNA monitoring has advanced biomarker-driven treatment selection. He is transforming breast cancer care through molecular classification and targeted therapy development.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Fabrice Andre 的研究动态
Follow Fabrice Andre's research updates
留下邮箱，当我们发布与 Fabrice Andre（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment